Elicio Therapeutics Correlations

ELTX Stock   5.12  0.11  2.20%   
The current 90-days correlation between Elicio Therapeutics and Kiora Pharmaceuticals is 0.07 (i.e., Significant diversification). The correlation of Elicio Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Elicio Therapeutics Correlation With Market

Good diversification

The correlation between Elicio Therapeutics and DJI is -0.08 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Elicio Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elicio Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Elicio Stock please use our How to Invest in Elicio Therapeutics guide.

Moving together with Elicio Stock

  0.69VERA Vera TherapeuticsPairCorr
  0.61VRDN Viridian TherapeuticsPairCorr

Moving against Elicio Stock

  0.73VALN Valneva SE ADR Downward RallyPairCorr
  0.71DRRX DurectPairCorr
  0.68DTIL Precision BioSciencesPairCorr
  0.65VRCA Verrica PharmaceuticalsPairCorr
  0.63VRAX Virax Biolabs GroupPairCorr
  0.61VCNX VaccinexPairCorr
  0.5VINC Vincerx PharmaPairCorr
  0.47VIRX Viracta TherapeuticsPairCorr
  0.46DYAI Dyadic InternationalPairCorr
  0.44EQ EquilliumPairCorr
  0.4VIGL Vigil NeurosciencePairCorr
  0.39DNTH Dianthus TherapeuticsPairCorr
  0.38VERV Verve TherapeuticsPairCorr
  0.37DRMA Dermata TherapeuticsPairCorr
  0.36ME 23Andme HoldingPairCorr
  0.68VTGN VistaGen TherapeuticsPairCorr
  0.68ENTA Enanta PharmaceuticalsPairCorr
  0.63VXRT Vaxart IncPairCorr
  0.59ENVB Enveric BiosciencesPairCorr
  0.5EDIT Editas MedicinePairCorr
  0.48EDSA Edesa Biotech Fiscal Year End 20th of December 2024 PairCorr
  0.46ELEV Elevation OncologyPairCorr
  0.44VRPX Virpax PharmaceuticalsPairCorr
  0.42EPIX ESSA Pharma Fiscal Year End 10th of December 2024 PairCorr
  0.35EOLS Evolus IncPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SONNZVSA
PHIOSONN
RNAZZURA
ZVSAKPRX
PHIOZVSA
PHIOKPRX
  
High negative correlations   
RNAZKPRX
RNAZSONN
RNAZZVSA
QNRXPHIO
ZURAZVSA
QNRXZVSA

Risk-Adjusted Indicators

There is a big difference between Elicio Stock performing well and Elicio Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Elicio Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Elicio Therapeutics Corporate Management

Joy SeymourVP AffairsProfile
Esther WelkowskySenior DevelopmentProfile
Peter DeMuthChief OfficerProfile
Michael DiVecchiaSenior ResourcesProfile
Megan FiloonSecretary CounselProfile
Brian PiekosChief OfficerProfile